Chargement en cours...
A chlorzoxazone-baclofen combination improves cerebellar impairment in spinocerebellar ataxia type 1
BACKGROUND: A combination of central muscle relaxants, chlorzoxazone and baclofen (chlorzoxazone-baclofen), has been proposed for treatment of cerebellar symptoms in human spinocerebellar ataxia (SCA). However, central muscle relaxants can worsen balance. The optimal dose for target engagement witho...
Enregistré dans:
| Publié dans: | Mov Disord |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7987844/ https://ncbi.nlm.nih.gov/pubmed/33151010 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mds.28355 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|